Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy - Contacts and Locations

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	Related Studies

Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

This study is ongoing, but not recruiting participants.
Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00015977

Locations


United States, Illinois
	University of Chicago Cancer Research Center
	Chicago, Illinois, United States, 60637-1470

Sponsors and Collaborators

University of Chicago

National Cancer Institute (NCI)

Investigators


Study Chair:	Thomas F. Gajewski, MD, PhD	University of Chicago